Abstract
There is increasing clinical evidence from observational studies, that combination therapy of daptomycin with rifampin is a valuable treatment option for biofilm-associated difficult to treat Staphylococcus aureus infections such as osteomyelitis, prosthetic joint infection and endocarditis. However, two studies analyzing a limited number of S. aureus isolates reported an antagonism of those two drugs questioning the benefit of this combination. To estimate the frequency of this possible antagonism, we performed in vitro checkerboard assays on 58 consecutive clinical isolates of S. aureus (MSSA n = 9, MRSA n = 49). We determined the fractional inhibitory concentration index (FICI) and the susceptible breakpoint index (SBPI). All isolates were characterized by a microprobe array detecting 336 different genes/alleles to ensure their non-clonal origin. For all isolates, the FICI was between 1.00 and 1.25 indicating additive effects for the daptomycin/rifampin combination. Neither antagonism nor synergism as defined by the FICI was found for any of the isolates. Based on these data, there is no evidence to advise against the daptomycin/rifampin combination therapy.
References
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Mark C EnrightBrian G Spratt
Jan 16, 2007·Antimicrobial Agents and Chemotherapy·Kim CreditoPeter C Appelbaum
Jan 24, 2008·The Annals of Pharmacotherapy·Graeme N ForrestLawrence V Friedrich
May 13, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S MoneckeR Ehricht
Jul 22, 2009·Antimicrobial Agents and Chemotherapy·J M MiróUNKNOWN Hospital Clinic Experimental Endocarditis Study Group
Oct 29, 2009·The Journal of Antimicrobial Chemotherapy·K E N Milne, I M Gould
Jan 6, 2010·Critical Care Medicine·Young Ju JungChae-Man Lim
Oct 6, 2010·Antimicrobial Agents and Chemotherapy·C GarrigósJ Ariza
Jan 7, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Catherine LiuUNKNOWN Infectious Diseases Society of America
Aug 10, 2011·Antimicrobial Agents and Chemotherapy·Azzam Saleh-MghirAnne-Claude Crémieux
Aug 19, 2011·Blood Purification·Shih-Yi LinChiu-Ching Huang
Aug 23, 2011·Diagnostic Microbiology and Infectious Disease·Theodoros KelesidisOtto O Yang
Sep 19, 2012·Infection·Y AchermannW Zimmerli
Mar 23, 2013·International Orthopaedics·Kheeldass JugunIlker Uçkay
May 8, 2013·Antimicrobial Agents and Chemotherapy·Warren E RoseDennis G Maki
Aug 10, 2013·The Journal of Antimicrobial Chemotherapy·Ravina KullarMichael J Rybak
Oct 31, 2014·The Journal of Antimicrobial Chemotherapy·Jonathan A T SandoeRichard Watkin
Jun 13, 2015·PloS One·Claudia SteinMathias W Pletz
Citations
Apr 6, 2017·Medizinische Klinik, Intensivmedizin und Notfallmedizin·S WeisM W Pletz
Dec 7, 2017·Frontiers in Microbiology·Irshad S SharafutdinovOliwia Makarewicz
Jun 15, 2016·Antimicrobial Agents and Chemotherapy·Rym BoudjemaaKarine Steenkeste
Nov 19, 2019·Frontiers in Pharmacology·Ruo-Yue HuangHualin Fu
Oct 19, 2019·The Journal of Antibiotics·Maria V GolikovaAlexander A Firsov
Nov 23, 2017·Frontiers in Microbiology·Bing YangYinsheng Qiu
May 1, 2021·Journal of Clinical Medicine·Annemieke BloemNelianne J Verkaik